What is ResTORbio?
ResTORbio operates within the beauty and personal care sector, offering a comprehensive range of skincare, haircare, make-up, and massage products. The company focuses on rejuvenating skin and hair, providing beauty tips, and publishing product reviews. Their business model centers on empowering consumers with advanced skincare techniques and high-quality cosmetic products, aiming to facilitate informed purchasing decisions through detailed content and product comparisons. This strategic focus on consumer education and product efficacy is a key differentiator in the competitive beauty market.
How much funding has ResTORbio raised?
ResTORbio has raised a total of $65M across 2 funding rounds:
Series A
$25M
Series B
$40M
Series A (2017): $25M, investors not publicly disclosed
Series B (2017): $40M led by Quan Capital, OrbiMed, Nest Bio Ventures, Fidelity Management & Research Company, and Rock Springs Capital
Key Investors in ResTORbio
Quan Capital
Quan Capital is an international alternative investment firm specializing in control-oriented investments in small- to medium-sized enterprises. They leverage management consulting roots and extensive investment experience across North America, Europe, and Asia to drive transformational change and operational improvements in businesses.
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. They invest in companies at various stages of development, from early-stage ventures to established organizations.
Fidelity Management & Research Company
Fidelity Investments is a financial services company providing a broad range of investment, wealth management, retirement planning, brokerage, and advisory solutions for individuals and institutions. They offer access to investment products, financial planning resources, and trading platforms.
What's next for ResTORbio?
With a recent major strategic investment and a history of substantial capital raises, ResTORbio is poised for significant growth. The company's enterprise-level funding suggests a focus on scaling operations, expanding its product lines, and potentially entering new markets. Future developments are likely to involve further innovation in beauty technology and product formulation, supported by strategic partnerships and continued investment in research and development. The company's trajectory indicates a strong push towards solidifying its market position and enhancing its consumer offerings.
See full ResTORbio company page
